Wealth Dimensions Group Ltd. Has $288,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Wealth Dimensions Group Ltd. decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 25.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 910 shares of the insurance provider’s stock after selling 304 shares during the quarter. Wealth Dimensions Group Ltd.’s holdings in Humana were worth $288,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC grew its stake in shares of Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after acquiring an additional 1,955,375 shares during the last quarter. Marshall Wace LLP raised its stake in Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after purchasing an additional 774,085 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after purchasing an additional 738,701 shares during the period. Baupost Group LLC MA acquired a new stake in Humana in the 2nd quarter worth $156,933,000. Finally, Thrivent Financial for Lutherans increased its holdings in shares of Humana by 639.8% during the 2nd quarter. Thrivent Financial for Lutherans now owns 385,782 shares of the insurance provider’s stock worth $144,147,000 after purchasing an additional 333,636 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and increased their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Oppenheimer decreased their price objective on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Truist Financial cut their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Stephens reiterated an “equal weight” rating and set a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $315.86.

Humana Stock Performance

Humana stock opened at $298.11 on Friday. The stock has a 50-day simple moving average of $276.83 and a 200 day simple moving average of $330.68. The stock has a market capitalization of $35.90 billion, a price-to-earnings ratio of 26.40, a P/E/G ratio of 2.33 and a beta of 0.52. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, research analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.19%. Humana’s payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.